Cargando…

A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2

Class B1 of G protein-coupled receptors (GPCRs) comprises 15 members activated by physiologically important peptide hormones. Among them, vasoactive intestinal polypeptide receptor 2 (VIP2R) is expressed in the central and peripheral nervous systems and involved in a number of pathophysiological con...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yingna, Feng, Wenbo, Zhou, Qingtong, Liang, Anyi, Li, Jie, Dai, Antao, Zhao, Fenghui, Yan, Jiahui, Chen, Chuan-Wei, Li, Hao, Zhao, Li-Hua, Xia, Tian, Jiang, Yi, Xu, H. Eric, Yang, Dehua, Wang, Ming-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046186/
https://www.ncbi.nlm.nih.gov/pubmed/35477937
http://dx.doi.org/10.1038/s41467-022-30041-z
_version_ 1784695470515290112
author Xu, Yingna
Feng, Wenbo
Zhou, Qingtong
Liang, Anyi
Li, Jie
Dai, Antao
Zhao, Fenghui
Yan, Jiahui
Chen, Chuan-Wei
Li, Hao
Zhao, Li-Hua
Xia, Tian
Jiang, Yi
Xu, H. Eric
Yang, Dehua
Wang, Ming-Wei
author_facet Xu, Yingna
Feng, Wenbo
Zhou, Qingtong
Liang, Anyi
Li, Jie
Dai, Antao
Zhao, Fenghui
Yan, Jiahui
Chen, Chuan-Wei
Li, Hao
Zhao, Li-Hua
Xia, Tian
Jiang, Yi
Xu, H. Eric
Yang, Dehua
Wang, Ming-Wei
author_sort Xu, Yingna
collection PubMed
description Class B1 of G protein-coupled receptors (GPCRs) comprises 15 members activated by physiologically important peptide hormones. Among them, vasoactive intestinal polypeptide receptor 2 (VIP2R) is expressed in the central and peripheral nervous systems and involved in a number of pathophysiological conditions, including pulmonary arterial hypertension, autoimmune and psychiatric disorders, in which it is thus a valuable drug target. Here, we report the cryo-electron microscopy structure of the human VIP2R bound to its endogenous ligand PACAP27 and the stimulatory G protein. Different from all reported peptide-bound class B1 GPCR structures, the N-terminal α-helix of VIP2R adopts a unique conformation that deeply inserts into a cleft between PACAP27 and the extracellular loop 1, thereby stabilizing the peptide-receptor interface. Its truncation or extension significantly decreased VIP2R-mediated cAMP accumulation. Our results provide additional information on peptide recognition and receptor activation among class B1 GPCRs and may facilitate the design of better therapeutics.
format Online
Article
Text
id pubmed-9046186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90461862022-04-29 A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2 Xu, Yingna Feng, Wenbo Zhou, Qingtong Liang, Anyi Li, Jie Dai, Antao Zhao, Fenghui Yan, Jiahui Chen, Chuan-Wei Li, Hao Zhao, Li-Hua Xia, Tian Jiang, Yi Xu, H. Eric Yang, Dehua Wang, Ming-Wei Nat Commun Article Class B1 of G protein-coupled receptors (GPCRs) comprises 15 members activated by physiologically important peptide hormones. Among them, vasoactive intestinal polypeptide receptor 2 (VIP2R) is expressed in the central and peripheral nervous systems and involved in a number of pathophysiological conditions, including pulmonary arterial hypertension, autoimmune and psychiatric disorders, in which it is thus a valuable drug target. Here, we report the cryo-electron microscopy structure of the human VIP2R bound to its endogenous ligand PACAP27 and the stimulatory G protein. Different from all reported peptide-bound class B1 GPCR structures, the N-terminal α-helix of VIP2R adopts a unique conformation that deeply inserts into a cleft between PACAP27 and the extracellular loop 1, thereby stabilizing the peptide-receptor interface. Its truncation or extension significantly decreased VIP2R-mediated cAMP accumulation. Our results provide additional information on peptide recognition and receptor activation among class B1 GPCRs and may facilitate the design of better therapeutics. Nature Publishing Group UK 2022-04-27 /pmc/articles/PMC9046186/ /pubmed/35477937 http://dx.doi.org/10.1038/s41467-022-30041-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Xu, Yingna
Feng, Wenbo
Zhou, Qingtong
Liang, Anyi
Li, Jie
Dai, Antao
Zhao, Fenghui
Yan, Jiahui
Chen, Chuan-Wei
Li, Hao
Zhao, Li-Hua
Xia, Tian
Jiang, Yi
Xu, H. Eric
Yang, Dehua
Wang, Ming-Wei
A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
title A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
title_full A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
title_fullStr A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
title_full_unstemmed A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
title_short A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
title_sort distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046186/
https://www.ncbi.nlm.nih.gov/pubmed/35477937
http://dx.doi.org/10.1038/s41467-022-30041-z
work_keys_str_mv AT xuyingna adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT fengwenbo adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT zhouqingtong adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT lianganyi adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT lijie adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT daiantao adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT zhaofenghui adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT yanjiahui adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT chenchuanwei adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT lihao adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT zhaolihua adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT xiatian adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT jiangyi adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT xuheric adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT yangdehua adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT wangmingwei adistinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT xuyingna distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT fengwenbo distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT zhouqingtong distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT lianganyi distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT lijie distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT daiantao distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT zhaofenghui distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT yanjiahui distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT chenchuanwei distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT lihao distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT zhaolihua distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT xiatian distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT jiangyi distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT xuheric distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT yangdehua distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2
AT wangmingwei distinctiveligandrecognitionmechanismbythehumanvasoactiveintestinalpolypeptidereceptor2